
The complications of weight loss by Angela Rieck
The FDA recently announced that Novo Nordisk’s semaglutide GLP-1 medication (Ozempic and Wegovy) is no longer in short supply. Before this announcement, the FDA permitted compounded GLP-1 products to be sold at much lower prices to maintain supplies. But, …